Papanek Julie Grant, Director at Day One Biopharmaceuticals, Inc. (DAWN), sold 9,469 shares at $23.21 ($220K) on 2022-09-01, disclosed to the SEC on 2022-09-06.
Open-market sale of $220k DAWN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.21 | 4,469 | $104K | 47.1% |
| 2 | $23.21 | 4,469 | $104K | 47.1% |
| 3 | $23.80 | 531 | $13K | 5.7% |
| Total | $23.24 avg | 9,469 | $220K | 100% |
| Filing → |
| DAWN | SELL | 2022-07-20 | $52K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $25K | — | Filing → |
| DAWN | SELL | 2022-07-12 | $36K | — | Filing → |